Nemvaleukin alfa produced a disease control rate of 50% in advanced melanoma and RCC.
Jax DiEugenio
Advertisement
Jax DiEugenio is an assistant editor for OncLive.
Articles by Jax DiEugenio
Advertisement
- NP/PA Connect
- News
- Media
- Conferences
- Events
- Publication
- CME/CE
- Resources
- Editorial Advisory Board
- Partners
- Subscribe